Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043424
Filing Date
2021-08-11
Accepted
2021-08-11 16:06:19
Documents
78
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvmd-10q_20210630.htm   iXBRL 10-Q 3309121
2 EX-10.1 rvmd-ex101_328.htm EX-10.1 37178
3 EX-10.2 rvmd-ex102_557.htm EX-10.2 25547
4 EX-31.1 rvmd-ex311_7.htm EX-31.1 21486
5 EX-31.2 rvmd-ex312_9.htm EX-31.2 21663
6 EX-32.1 rvmd-ex321_8.htm EX-32.1 8486
7 EX-32.2 rvmd-ex322_6.htm EX-32.2 8544
8 GRAPHIC gu2snpn0cr2x000001.jpg GRAPHIC 67485
  Complete submission text file 0001564590-21-043424.txt   11004143

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA rvmd-20210630.xsd EX-101.SCH 60645
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rvmd-20210630_cal.xml EX-101.CAL 61070
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvmd-20210630_def.xml EX-101.DEF 187468
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmd-20210630_lab.xml EX-101.LAB 469055
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmd-20210630_pre.xml EX-101.PRE 348107
14 EXTRACTED XBRL INSTANCE DOCUMENT rvmd-10q_20210630_htm.xml XML 2195802
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39219 | Film No.: 211163435
SIC: 2836 Biological Products, (No Diagnostic Substances)